RPP SRL

Lobbying Organisation RPP SRL

Date published 10 May, 2023

Relevant Matter Legislation

Public Policy Area Health

Period 1 Jan, 2023 to 30 Apr, 2023

Specific Details Educational initiative and questionaire on gene therapy and related awareness

Intended results Greater awareness of gene therapy and related issues in the anticipation of legislation and policy changes. Additionally, to request the MEPs to respond to a questionaire to measure the current levels of understanding among policy makers of gene therapy. To request Mr Billy Kelleher to host the educational meeting

Name of person primarily responsible for lobbying on this activity Mehitabel Moller

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name Pfizer S.A.

CRO number (if applicable)

Company address Boulevard de la Plaine 17, 1050 Ixelles

Main business or activity

Company website https://www.pfizer.com

Contact email address yordan.aleksandrov@pfizer.com

Contact phone number +32 2 554 6211

Contact address Boulevard de la Plaine 17, 1050 Ixelles

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

The MEP was requested to complete a questionaire on gene therapy

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Deirdre Clune MEP (European Parliament)

Billy Kelleher MEP (European Parliament)